Ono Pharmaceutical

Biotech

Ono inks deal for antibody against ‘very challenging’ I-O target

After seeing its partner’s work on a “new and very challenging immuno-oncology target,” Ono decided to commit to a $279 million financial package.
Nick Paul Taylor Mar 31, 2022 7:58am

Vasella helps Numab to CHF22M round ahead of cancer trial start

Mar 9, 2020 7:00am

Ono pumps cash into U.K. immuno-oncology R&D effort

Mar 27, 2019 9:00am

Bristol-Myers boosts I-O offering with new Ono drug deal

Dec 14, 2017 5:05am

Array adds Ono as Japanese partner for MEK/BRAF combo

May 31, 2017 7:38am

Ono takes a long look at Seikagaku arthritis candidate

May 12, 2017 6:58am